Developer docs
API playgroundTry for free, no card

Search company profiles

TileDB

Full company profile

uuid00003vm

Namestring
TileDB
Legal namestring
TileDB, Inc.
Websiteurl
tiledb.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

TileDB, Inc. is a privately held, Cambridge, Massachusetts-based database software company founded in February 2017 by Stavros Papadopoulos and spun out of MIT and Intel Labs in May 2017. The company builds a multimodal database platform built on proprietary multi-dimensional array technology, with its flagship product TileDB Cloud providing a serverless engine for organizing, structuring, collaborating on, and analyzing diverse scientific data types — including genomics, single-cell, biomedical imaging, multi-omics, clinical, and structured data — within a single unified environment. Notable technical components include the open-source TileDB storage engine, the SOMA API specification co-developed with the Chan Zuckerberg Initiative and implemented in Python and R via TileDB-SOMA, a Trusted Research Environment supporting federated queries across organizations without data movement, and FAIR-compliance tooling for downstream AI/ML use. TileDB Carrara, launched in December 2025, extends the platform as a Snowflake Connected App for Healthcare & Life Sciences that bridges scientific multimodal data with Snowflake's AI Data Cloud.

TileDB monetizes primarily through annual cloud platform subscriptions priced at $10 per seat per month and $50 per vCPU per month (purchased in blocks of 10 seats or 50 vCPUs and billed annually), supplemented by Dedicated Success Engineer professional services at $250 per hour sold in 100-hour increments, with a representative example package of $31,200 per year for 10 seats plus 50 vCPUs. Pricing is publicly disclosed, and go-to-market is enterprise field sales targeting pharmaceutical, biotechnology, healthcare providers, diagnostics, and research institutions, complemented by a Trusted Partner Network that includes Accenture, Cognizant, Deloitte, EPAM, Zifo, AWS, Databricks, Snowflake, IBM, Microsoft, and Nvidia. The company has raised approximately $57 million in disclosed funding across seed, Series 1, Series 2, and corporate-backed rounds, with Two Bear Capital, AlleyCorp, Nexus Venture Partners, Intel Capital, and Big Pi as the most active financial backers and strategic investments from Amgen Ventures, Lockheed Martin Ventures, NTT Docomo Ventures, and Verizon Ventures; named enterprise customers include Johnson & Johnson, Takeda, Boehringer Ingelheim, Amgen, Alexion, Quest Diagnostics, Bio-Rad, Lockheed Martin, Cellarity, Phenomic AI, Rady Children's Institute, and the Chan Zuckerberg Initiative.

Short descriptiontext

TileDB is a Cambridge-based multimodal database software company providing a unified platform for managing genomics, single-cell, imaging, and other scientific data, serving pharmaceutical, biotech, diagnostics, and healthcare enterprises.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
multimodal database platform, genomic data management, scientific data analytics, cloud database engine, life sciences data
Industry4 codes
PRIMARYHDAEABAD
Data Platform (Unified Data & Analytics) Suites
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Data Warehousing, Lakehouse & Data Platforms
SECONDARYHDAEABAC
Data Lake Platforms
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Data Warehousing, Lakehouse & Data Platforms
SECONDARYHLACAIAA
Healthcare Data Lakes, Lakehouses & Cloud Warehouses
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHDAEAIAK
Data/Apps Connectivity & Adapters (Connectors, Drivers, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Application Integration & iPaaS (API Management, ESB)
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services51821
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Scientific Multimodal Database Platform
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Cloud Platform Subscription
TypeSubscription Recurring
Description

TileDB Cloud subscription based on user seats ($10/month per seat, billed annually in increments of 10 seats at $1,200/year) and vCPU compute ($50/month per vCPU, billed annually in increments of 50 vCPUs at $30,000/year)

2Dedicated Success Engineer Services
TypeProfessional Services
Description

Professional services provided by subject matter experts (bioinformaticians, engineers, database architects) at $250/hour, billed in 100-hour increments ($25,000/year)

Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1User Seat License - $10/month per seat, billed annually
ModelPer seatBilling cadenceAnnual
Notes

1 Seat for $10/month. Purchased in increments of 10 seats ($1,200/year). Billed annually.

2vCPU Compute - $50/month per vCPU, billed annually
ModelUsage-basedBilling cadenceAnnual
Notes

1 vCPU for $50/month. Purchased in increments of 50 vCPUs ($30,000/year). Billed annually.

3Dedicated Success Engineer - $250/hour professional services
ModelUnit PricingBilling cadenceAnnual
Notes

DSE for $250/hour. Subject matter experts (bioinformaticians, engineers, database architects). Purchased in increments of 100 hours ($25,000/year).

GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

TileDB provides a cloud-native, multimodal database platform built on proprietary multi-dimensional array technology that enables organizations to organize, structure, collaborate on, and analyze diverse scientific data types (genomics, single-cell, imaging, clinical, and time-series) within a single unified system. The flagship TileDB Cloud offering is a serverless, array-powered engine that scales to petabyte-scale workloads with up to 97% cost reduction versus file-based approaches and supports federated queries across institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Reduced storage costs by up to 97% compared to file-based approaches
+4 more records
Product overview1 text field

TileDB offers a unified multimodal database platform built on multi-dimensional array technology. The core product is TileDB Cloud, a universal database that manages and analyzes all data types (genomics, imaging, single-cell, clinical, and structured data) in one platform. TileDB Carrara is an omnimodal data intelligence platform launched as a Snowflake Connected App for Healthcare & Life Sciences. TileDB-SOMA provides Python and R APIs for single-cell data access. The platform features a Trusted Research Environment supporting federated queries and a FAIR Compliance Framework. TileDB Cloud uses an array-powered serverless engine that scales to petabyte-scale use cases with up to 97% cost reduction versus file-based approaches.

Product and service4 records
1TileDB Cloud
CategoryCore Database Platform
Description

The flagship cloud platform providing a universal, serverless database for managing and analyzing complex, high-dimensional scientific data at petabyte scale, with array-powered engine and shared remote access without moving physical data. Used by pharma, biotech, diagnostics, and research institutions for genomics, single-cell, imaging, and multi-omics workloads.

2TileDB Carrara
CategoryOmnimodal Data Intelligence Platform
Description

An omnimodal data intelligence platform launched as a Snowflake Connected App for Healthcare & Life Sciences. Bridges scientific and multimodal data within Snowflake's AI Data Cloud, enabling unified data governance and access across complex multimodal and structured datasets for healthcare and life sciences organizations.

3TileDB-SOMA
CategorySingle-Cell Data API
Description

Open-source software libraries implementing the SOMA API specification for storing and analyzing large collections of single-cell experiments directly on cloud object stores. Provides Python and R implementations enabling cross-language access to single-cell data for interoperability between tools like Anndata/Scanpy and Seurat.

4Dedicated Success Engineer Services
CategoryProfessional Services
Description

Professional services provided by subject matter experts including bioinformaticians, engineers, and database architects at $250/hour, billed in 100-hour increments, to support customer implementations and success.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-17
Description

Integration partnership to launch TileDB Carrara as a Snowflake Connected App for Healthcare & Life Sciences. Enables joint customers to manage and analyze complex scientific and multimodal data across TileDB and Snowflake in a unified environment.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-30
Description

Partnership with Kepler AI and Tahoe Therapeutics to develop an AI-powered platform for analyzing large-scale single-cell datasets. Platform enables real-time queries on 100 million cells, advancing computational biology and drug discovery research.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-30
Description

Partnership with TileDB and Kepler AI to develop an AI-powered platform for analyzing large-scale single-cell datasets. Platform enables real-time queries on 100 million cells, advancing computational biology and drug discovery research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with Chan Zuckerberg Initiative on SOMA open-source API specification and TileDB-SOMA libraries for single-cell data access. SOMA enables researchers to query large single-cell biology datasets directly in cloud storage without loading into RAM.

5AWS
Strategic tierCoreTypeTechnology or Integration
Description

Featured technology partner with dedicated TileDB + AWS integration resources. AWS marketplace and cloud infrastructure partnership.

tiledb.com
Strategic tierCoreTypeTechnology or Integration
Description

Featured technology partner with Databricks integration for unified analytics on multimodal data.

7Zifo
Strategic tierFeaturedTypeImplementation/ SI/ Consulting Partner
Description

Featured consulting and systems integration partner specializing in scientific data infrastructure.

tiledb.com
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Systems integration partner in TileDB's Trusted Partner Network.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Systems integration partner in TileDB's Trusted Partner Network.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Systems integration partner in TileDB's Trusted Partner Network.

11EPAM
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Systems integration partner in TileDB's Trusted Partner Network.

tiledb.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership combining TileDB Carrara's unified data architecture with Strand Life Sciences' AI-driven bioinformatics to overcome genomic data bottlenecks and accelerate precision medicine.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DNAnexus is a cloud-based genomics and biomedical data management platform serving pharma, diagnostics, and research institutions. It is a direct competitor to TileDB in the life sciences data platform category, with overlapping customers (e.g., Quest, top pharma) and a comparable focus on biobank-scale variant and multi-omics data.

TypeBroad incumbent
Description

Palantir's Foundry platform is widely deployed at large pharma and biotech customers for integrating clinical, research, and operational data. It is an incumbent for the same enterprise data unification use cases TileDB targets in life sciences, though with a broader, less-specialized architecture.

TypeDirect peer
Description

Lifebit provides a federated genomics and biomedical data platform with a Trusted Research Environment for pharma and public-sector genomics. It directly competes with TileDB on multimodal life sciences data, federated queries, and FAIR-compliant collaboration across institutions.

TypeDirect peer
Description

BC Platforms offers a genomics and real-world data platform for pharma, biobanks, and healthcare systems, with a focus on secure data sharing and federated analytics. It is comparable to TileDB in providing infrastructure for life sciences data sharing and analysis.

TypeEmerging player
Description

TetraScience is a life sciences R&D data cloud focused on lab and scientific instrument data, with growing overlap into multimodal scientific data platforms serving pharma. It is comparable to TileDB as a specialized scientific data infrastructure player targeting pharma R&D, though with a stronger lab-execution focus.

TypeDirect peer
Description

Velsera operates a genomics and multi-omics data platform for pharma, diagnostics, and research customers, including the GRAF™ workflow and data management offerings. It is comparable to TileDB in serving pharma R&D with cloud-based bioinformatics and biomedical data infrastructure.

TypeBroad incumbent
Description

AWS HealthOmics is Amazon's managed service for genomics, transcriptomics, and other omics data, directly addressing the same pharmaceutical and diagnostics use cases as TileDB. It benefits from native AWS integration and deep enterprise sales reach across TileDB's customer base.

TypeBroad incumbent
Description

Snowflake is both a TileDB partner (via TileDB Carrara as a Connected App) and a broad incumbent. Its Healthcare & Life Sciences Data Cloud competes for the same pharma and diagnostics workloads, and could expand native multimodal capabilities that overlap with TileDB's differentiators.

TypeBroad incumbent
Description

Databricks is a broad lakehouse and data + AI platform with a dedicated Healthcare and Life Sciences vertical. While not purpose-built for multimodal scientific data the way TileDB is, it increasingly competes in the same buyer accounts and offers integrated genomics, imaging, and clinical data capabilities at much greater scale.

TypeDirect peer
Description

Aridhia provides a Trusted Research Environment and biomedical data analytics platform used by hospitals, research consortia, and life sciences organizations. It competes with TileDB on secure, federated, FAIR-compliant data collaboration for clinical and research data.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TileDB

Scientific Multimodal Database Platformtiledb.com

TileDB is a Cambridge-based multimodal database software company providing a unified platform for managing genomics, single-cell, imaging, and other scientific data, serving pharmaceutical, biotech, diagnostics, and healthcare enterprises.

What TileDB does

TileDB, Inc. is a privately held, Cambridge, Massachusetts-based database software company founded in February 2017 by Stavros Papadopoulos and spun out of MIT and Intel Labs in May 2017. The company builds a multimodal database platform built on proprietary multi-dimensional array technology, with its flagship product TileDB Cloud providing a serverless engine for organizing, structuring, collaborating on, and analyzing diverse scientific data types — including genomics, single-cell, biomedical imaging, multi-omics, clinical, and structured data — within a single unified environment. Notable technical components include the open-source TileDB storage engine, the SOMA API specification co-developed with the Chan Zuckerberg Initiative and implemented in Python and R via TileDB-SOMA, a Trusted Research Environment supporting federated queries across organizations without data movement, and FAIR-compliance tooling for downstream AI/ML use. TileDB Carrara, launched in December 2025, extends the platform as a Snowflake Connected App for Healthcare & Life Sciences that bridges scientific multimodal data with Snowflake's AI Data Cloud.

TileDB monetizes primarily through annual cloud platform subscriptions priced at $10 per seat per month and $50 per vCPU per month (purchased in blocks of 10 seats or 50 vCPUs and billed annually), supplemented by Dedicated Success Engineer professional services at $250 per hour sold in 100-hour increments, with a representative example package of $31,200 per year for 10 seats plus 50 vCPUs. Pricing is publicly disclosed, and go-to-market is enterprise field sales targeting pharmaceutical, biotechnology, healthcare providers, diagnostics, and research institutions, complemented by a Trusted Partner Network that includes Accenture, Cognizant, Deloitte, EPAM, Zifo, AWS, Databricks, Snowflake, IBM, Microsoft, and Nvidia. The company has raised approximately $57 million in disclosed funding across seed, Series 1, Series 2, and corporate-backed rounds, with Two Bear Capital, AlleyCorp, Nexus Venture Partners, Intel Capital, and Big Pi as the most active financial backers and strategic investments from Amgen Ventures, Lockheed Martin Ventures, NTT Docomo Ventures, and Verizon Ventures; named enterprise customers include Johnson & Johnson, Takeda, Boehringer Ingelheim, Amgen, Alexion, Quest Diagnostics, Bio-Rad, Lockheed Martin, Cellarity, Phenomic AI, Rady Children's Institute, and the Chan Zuckerberg Initiative.

TileDB firmographics

Firmographics
Name
TileDB
Legal name
TileDB, Inc.
Website
https://tiledb.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
TileDB is a Cambridge-based multimodal database software company providing a unified platform for managing genomics, single-cell, imaging, and other scientific data, serving pharmaceutical, biotech, diagnostics, and healthcare enterprises.
Ownership category
akta.pro rank

TileDB industry classification

Industry
Product category
Scientific Multimodal Database Platform
NAICS
Computer Systems Design and Related Services (54151), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHDAEABAD
Data Platform (Unified Data & Analytics) Suites
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Data Warehousing, Lakehouse & Data Platforms
SECONDARYHDAEABAC
Data Lake Platforms
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Data Warehousing, Lakehouse & Data Platforms
SECONDARYHLACAIAA
Healthcare Data Lakes, Lakehouses & Cloud Warehouses
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHDAEAIAK
Data/Apps Connectivity & Adapters (Connectors, Drivers, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Application Integration & iPaaS (API Management, ESB)

Keywords

  • Multimodal database platform
  • Genomic data management
  • Scientific data analytics
  • Cloud database engine
  • Life sciences data

Where TileDB is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices1 record

Markets served

TileDB business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Cloud Platform Subscription: TileDB Cloud subscription based on user seats ($10/month per seat, billed annually in increments of 10 seats at $1,200/year) and vCPU compute ($50/month per vCPU, billed annually in increments of 50 vCPUs at $30,000/year)
  2. Dedicated Success Engineer Services: Professional services provided by subject matter experts (bioinformaticians, engineers, database architects) at $250/hour, billed in 100-hour increments ($25,000/year)

Pricing tiers

ModelBillingPrice
Per seatAnnualUser Seat License - $10/month per seat, billed annually
Usage-basedAnnualvCPU Compute - $50/month per vCPU, billed annually
Unit PricingAnnualDedicated Success Engineer - $250/hour professional services

Go-to-market motion1 record

Distribution channels4 records

Marketing channels10 records

TileDB product offering

Product offering

Core offering

TileDB provides a cloud-native, multimodal database platform built on proprietary multi-dimensional array technology that enables organizations to organize, structure, collaborate on, and analyze diverse scientific data types (genomics, single-cell, imaging, clinical, and time-series) within a single unified system. The flagship TileDB Cloud offering is a serverless, array-powered engine that scales to petabyte-scale workloads with up to 97% cost reduction versus file-based approaches and supports federated queries across institutions.

Product overview

TileDB offers a unified multimodal database platform built on multi-dimensional array technology. The core product is TileDB Cloud, a universal database that manages and analyzes all data types (genomics, imaging, single-cell, clinical, and structured data) in one platform. TileDB Carrara is an omnimodal data intelligence platform launched as a Snowflake Connected App for Healthcare & Life Sciences. TileDB-SOMA provides Python and R APIs for single-cell data access. The platform features a Trusted Research Environment supporting federated queries and a FAIR Compliance Framework. TileDB Cloud uses an array-powered serverless engine that scales to petabyte-scale use cases with up to 97% cost reduction versus file-based approaches.

Differentiator

Problem solved

Functional benefit

Products and services

  • TileDB Cloud The flagship cloud platform providing a universal, serverless database for managing and analyzing complex, high-dimensional scientific data at petabyte scale, with array-powered engine and shared remote access without moving physical data. Used by pharma, biotech, diagnostics, and research institutions for genomics, single-cell, imaging, and multi-omics workloads.
  • TileDB Carrara An omnimodal data intelligence platform launched as a Snowflake Connected App for Healthcare & Life Sciences. Bridges scientific and multimodal data within Snowflake's AI Data Cloud, enabling unified data governance and access across complex multimodal and structured datasets for healthcare and life sciences organizations.
  • TileDB-SOMA Open-source software libraries implementing the SOMA API specification for storing and analyzing large collections of single-cell experiments directly on cloud object stores. Provides Python and R implementations enabling cross-language access to single-cell data for interoperability between tools like Anndata/Scanpy and Seurat.
  • Dedicated Success Engineer Services Professional services provided by subject matter experts including bioinformaticians, engineers, and database architects at $250/hour, billed in 100-hour increments, to support customer implementations and success.

Quantifiable outcome

  • Reduced storage costs by up to 97% compared to file-based approaches
  • +4 more outcomes

Companies that use TileDB

Customer profile

Named customers11 records

Segments3 records

Ideal customer profiles4 records

TileDB technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

TileDB partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core, featured and minor.

  • SnowflakecoreTechnology or Integration · 17 December 2025Integration partnership to launch TileDB Carrara as a Snowflake Connected App for Healthcare & Life Sciences. Enables joint customers to manage and analyze complex scientific and multimodal data across TileDB and Snowflake in a unified environment.
  • Kepler AIcoreStrategic or Co-development Partner · 30 September 2025Partnership with Kepler AI and Tahoe Therapeutics to develop an AI-powered platform for analyzing large-scale single-cell datasets. Platform enables real-time queries on 100 million cells, advancing computational biology and drug discovery research.
  • Tahoe TherapeuticscoreStrategic or Co-development Partner · 30 September 2025Partnership with TileDB and Kepler AI to develop an AI-powered platform for analyzing large-scale single-cell datasets. Platform enables real-time queries on 100 million cells, advancing computational biology and drug discovery research.
  • Chan Zuckerberg InitiativecoreStrategic or Co-development PartnerCollaboration with Chan Zuckerberg Initiative on SOMA open-source API specification and TileDB-SOMA libraries for single-cell data access. SOMA enables researchers to query large single-cell biology datasets directly in cloud storage without loading into RAM.
  • AWScoreTechnology or IntegrationFeatured technology partner with dedicated TileDB + AWS integration resources. AWS marketplace and cloud infrastructure partnership.
  • DatabrickscoreTechnology or IntegrationFeatured technology partner with Databricks integration for unified analytics on multimodal data.
  • ZifofeaturedImplementation/ SI/ Consulting PartnerFeatured consulting and systems integration partner specializing in scientific data infrastructure.
  • AccentureminorImplementation/ SI/ Consulting PartnerSystems integration partner in TileDB's Trusted Partner Network.
  • CognizantminorImplementation/ SI/ Consulting PartnerSystems integration partner in TileDB's Trusted Partner Network.
  • DeloitteminorImplementation/ SI/ Consulting PartnerSystems integration partner in TileDB's Trusted Partner Network.
  • EPAMminorImplementation/ SI/ Consulting PartnerSystems integration partner in TileDB's Trusted Partner Network.
  • Strand Life SciencescoreStrategic or Co-development PartnerPartnership combining TileDB Carrara's unified data architecture with Strand Life Sciences' AI-driven bioinformatics to overcome genomic data bottlenecks and accelerate precision medicine.

Scale indicators6 records

Recent moves5 records

Expansion highlights2 records

TileDB competitors and assessment

Company assessment

Direct peers

  • DNAnexus: DNAnexus is a cloud-based genomics and biomedical data management platform serving pharma, diagnostics, and research institutions. It is a direct competitor to TileDB in the life sciences data platform category, with overlapping customers (e.g., Quest, top pharma) and a comparable focus on biobank-scale variant and multi-omics data.
  • Lifebit: Lifebit provides a federated genomics and biomedical data platform with a Trusted Research Environment for pharma and public-sector genomics. It directly competes with TileDB on multimodal life sciences data, federated queries, and FAIR-compliant collaboration across institutions.
  • BC Platforms: BC Platforms offers a genomics and real-world data platform for pharma, biobanks, and healthcare systems, with a focus on secure data sharing and federated analytics. It is comparable to TileDB in providing infrastructure for life sciences data sharing and analysis.
  • Velsera (formerly Seven Bridges Genomics): Velsera operates a genomics and multi-omics data platform for pharma, diagnostics, and research customers, including the GRAF™ workflow and data management offerings. It is comparable to TileDB in serving pharma R&D with cloud-based bioinformatics and biomedical data infrastructure.
  • Aridhia: Aridhia provides a Trusted Research Environment and biomedical data analytics platform used by hospitals, research consortia, and life sciences organizations. It competes with TileDB on secure, federated, FAIR-compliant data collaboration for clinical and research data.

Broad incumbents

  • Palantir Foundry: Palantir's Foundry platform is widely deployed at large pharma and biotech customers for integrating clinical, research, and operational data. It is an incumbent for the same enterprise data unification use cases TileDB targets in life sciences, though with a broader, less-specialized architecture.
  • AWS HealthOmics: AWS HealthOmics is Amazon's managed service for genomics, transcriptomics, and other omics data, directly addressing the same pharmaceutical and diagnostics use cases as TileDB. It benefits from native AWS integration and deep enterprise sales reach across TileDB's customer base.
  • Snowflake: Snowflake is both a TileDB partner (via TileDB Carrara as a Connected App) and a broad incumbent. Its Healthcare & Life Sciences Data Cloud competes for the same pharma and diagnostics workloads, and could expand native multimodal capabilities that overlap with TileDB's differentiators.
  • Databricks: Databricks is a broad lakehouse and data + AI platform with a dedicated Healthcare and Life Sciences vertical. While not purpose-built for multimodal scientific data the way TileDB is, it increasingly competes in the same buyer accounts and offers integrated genomics, imaging, and clinical data capabilities at much greater scale.

Emerging players

  • TetraScience: TetraScience is a life sciences R&D data cloud focused on lab and scientific instrument data, with growing overlap into multimodal scientific data platforms serving pharma. It is comparable to TileDB as a specialized scientific data infrastructure player targeting pharma R&D, though with a stronger lab-execution focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

TileDB social profiles

Digital presence

TileDB compliance and trust

Trust signal

Compliance2 records

TileDB financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TileDB leadership team

Management profile

Number of profiles

Profiles7 records

TileDB funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TileDB M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TileDB

What does TileDB do?

TileDB provides a cloud-native, multimodal database platform built on proprietary multi-dimensional array technology that enables organizations to organize, structure, collaborate on, and analyze diverse scientific data types (genomics, single-cell, imaging, clinical, and time-series) within a single unified system. The flagship TileDB Cloud offering is a serverless, array-powered engine that scales to petabyte-scale workloads with up to 97% cost reduction versus file-based approaches and supports federated queries across institutions.

Is TileDB a public or private company?

TileDB is a private company. It is classified as venture growth investor backed and is currently operating.

When was TileDB founded?

TileDB was founded in 2017. It employs 11 to 50 people.

Where is TileDB based?

TileDB is headquartered in Cambridge, United States, in the North America region.

How does TileDB make money?

Two revenue lines are on record. Cloud Platform Subscription is the primary driver. The others are dedicated Success Engineer Services.

Who are TileDB's main competitors?

Direct peers on record are DNAnexus, Lifebit, BC Platforms, Velsera (formerly Seven Bridges Genomics) and Aridhia. Broad incumbents are Palantir Foundry, AWS HealthOmics, Snowflake and Databricks. TetraScience is listed as an emerging player.

Does TileDB have an API?

Yes. TileDB offers the SOMA API specification, an open-source API designed to enable access to datasets modeled as annotated sparse 2D matrices. TileDB-SOMA provides Python and R implementations allowing single-cell researchers to access large cloud-based datasets from different programming languages, enabling interoperability between tools like Anndata/Scanpy and Seurat. TileDB Cloud also provides a REST API for cloud-based data management operations. Developer documentation is at cloud.tiledb.com/academy/home.

What industry is TileDB in?

TileDB's product category is Scientific Multimodal Database Platform. Its primary akta.pro industry code is HDAEABAD, Data Platform (Unified Data & Analytics) Suites, with a secondary code of HDAEABAC, Data Lake Platforms. Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsTileDB Transforms into Tile.ai: New Leadership and Investment Propel Data InnovationTileDB has rebranded as Tile.ai and introduced an Enterprise AI Data Substrate to secure data for AI applications. George Llado was appointed CEO, and a financing round led by Two Bear Capital supported the company. The company aims to keep the open-source TileDB array engine and is in private preview with select partners.TileTileDB rebrands as Tile.ai, names new CEO and secures strategic investmentTileDB rebranded as Tile.ai and introduced its Enterprise AI Data Substrate in private preview. The company appointed George Llado as CEO and secured a strategic investment led by Two Bear Capital with Amgen Ventures participation. The funding will support product development and go-to-market efforts.LinkedInToday TileDB becomes tile.ai, and I'm going back to founder mode. Heads-down on product and vision, rebuilding — in many ways from scratch — for a moment that demands it. It's the part of the job I…TileDB is rebranding to tile.ai, with George Llado taking the CEO role. The company is in private preview, backed by Amgen Ventures and Two Bear Capital. The shift reflects a focus on making data usable by AI.PR NewswireTileDB Rebrands as Tile.ai, Names New CEO and Secures Strategic InvestmentTileDB rebranded as Tile.ai and introduced its Enterprise AI Data Substrate in private preview. The company appointed George Llado as CEO and secured a strategic investment led by Two Bear Capital with Amgen Ventures. The funding will support product development and go-to-market efforts.RuntimewireTileDB becomes Tile.ai as founder hands CEO job to George LladoTileDB rebranded as Tile.ai on September 16, handing CEO duties to George Llado and returning founder Stavros Papadopoulos to product. The company launched the Enterprise AI Data Substrate in private preview, targeting regulated enterprises. No valuation or deployment figures were disclosed.eKathimerini.comDeep tech startups flourishDeep tech startups are developing innovations in Greece across robotics, healthcare, and drug development, with companies like TileDB managing complex data and Acumino working to make industrial robots more dexterous. According to Dealroom research, the European deep tech sector attracted $20.3 billion in venture capital last year, up from $16.9 billion in 2024 and $2.9 billion a decade ago, accounting for one-third of total VC flows. Greece's deep tech ecosystem remains embryonic compared to other countries, though many startups employ staff and founders in Greece while maintaining official headquarters abroad.YahooHow Investors Are Reacting To Snowflake (SNOW) Deepening Healthcare AI Integration With TileDB Carrara Connected AppIn December, TileDB announced the launch of TileDB Carrara as a Snowflake Connected App for Healthcare & Life Sciences, enabling joint customers to unify multimodal scientific data with tabular data in Snowflake for end-to-end AI and machine learning pipelines. The article analyzes Snowflake's investment narrative, projecting $7.8 billion revenue and $497.5 million earnings by 2028, requiring 23.8% annual revenue growth amid intensifying competition from hyperscale cloud providers. The analysis highlights that investors are focused on whether Snowflake's expanding AI product set can translate widespread experimentation into durable, broad-based revenue rather than short-term migration-driven consumption.PR NewswireTileDB Announces Integration with Snowflake to Launch TileDB Carrara to Bridge Scientific and Multimodal Data in AI Data CloudTileDB announced the launch of TileDB Carrara, an omnimodal data intelligence platform, as a Snowflake Connected App for Healthcare & Life Sciences, enabling organizations to unify complex scientific and multimodal data across both platforms. The integration provides unified catalog access, automatic credential setup via RSA Key Pair authentication, and streamlined Python access through Snowflake's SDK, allowing organizations to manage data assets from both TileDB arrays and Snowflake tables through a single interface. Healthcare and Life Sciences organizations can now integrate multiomics profiles, clinical imaging, electronic health records, and real-world evidence to enable AI systems and analytics leveraging complete data pictures.PR NewswireTileDB Ships First Version of Carrara, Introducing Omnimodal Data Intelligence PlatformTileDB announced controlled availability of Carrara, its first omnimodal data intelligence platform, on Oct. 7, 2025. The platform treats all data types as structured modalities, offering governance, performance, and scalability. It supports healthcare and life sciences, with future iterations planned for custom modalities and AI agents.TileDBThe Definitive Guide to Multimodal DatabasesThe article explains the concept of multimodal databases, systems that manage diverse data types within a single platform, and discusses their architecture, benefits, and use cases across various industries. It highlights TileDB's approach as an example of a multimodal database tailored for life sciences and scientific computing, emphasizing its features and suitability for complex data workloads.